Elevated Plasma Chemokines for Eosinophils in Neuromyelitis Optica Spectrum Disorders during Remission

Frontiers in Neurology
Yanping TongYongping Fan

Abstract

A prominent pathological feature of neuromyelitis optica spectrum disorders (NMOSD) is markedly greater eosinophilic infiltration than that seen in other demyelinating diseases, like multiple sclerosis (MS). Eosinophils express the chemokine receptor CCR3, which is activated by eotaxins (CCL11/eotaxin-1, CCL24/eotaxin-2, CCL26/eotaxin-3) and CCL13 [monocyte chemoattractant protein (MCP)-4]. Moreover, CCL13 is part of the chemokine set that activates CCR2. The present study aimed to evaluate plasma levels of eotaxins (CCL11, CCL24, and CCL26) and MCPs (CCL13, CCL2, CCL8, and CCL7) in patients with NMOSD during remission. Healthy controls (HC;n = 30) and patients with MS (n = 47) and NMOSD (n = 58) in remission were consecutively enrolled in this study between January 2016 and August 2017. Plasma CCL11, CCL24, CCL26, CCL2, CCL8, CCL7, CCL13, tumor necrosis factor (TNF)-α, and interleukin (IL)-1β levels were detected using the human cytokine multiplex assay. Plasma CCL13, CCL11, and CCL26 levels were all significantly higher in patients with NMOSD than in HC and patients with MS. No significant differences were found in the CCL13, CCL11, or CCL26 levels between patients with NMOSD receiving and not receiving immunosuppressive ther...Continue Reading

References

Nov 19, 1997·Journal of Leukocyte Biology·A D Luster, M E Rothenberg
Jun 22, 2002·Brain : a Journal of Neurology·Claudia F LucchinettiHans Lassmann
Dec 30, 2004·Neurology·Jorge Correale, Marcela Fiol
Jul 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·John J OsterholzerJeffrey L Curtis
Apr 24, 2007·Brain : a Journal of Neurology·Toshiyuki TakahashiYasuto Itoyama
Apr 23, 2008·Allergology International : Official Journal of the Japanese Society of Allergology·Toshimasa Aranami, Takashi Yamamura
Apr 25, 2009·Autoimmunity Reviews·Philippe SaikaliThierry Vincent
Dec 17, 2010·Multiple Sclerosis : Clinical and Laboratory Research·Jorge Correale, Marcela Fiol
Jan 29, 2011·The Biochemical Journal·James E Pease
Mar 10, 2011·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Dec 14, 2011·Laboratory Investigation; a Journal of Technical Methods and Pathology·Sabrina LisiMassimo D'Amore
Dec 29, 2011·Microbes and Infection·Christian J LechnerPeter T Soboslay
Jan 25, 2012·Annals of Neurology·Lukmanee TradtrantipA S Verkman
Oct 31, 2012·Neuroreport·Samira SaadounMarios C Papadopoulos
Nov 17, 2012·Nature Reviews. Immunology·Helene F RosenbergPaul S Foster
Apr 9, 2013·The Journal of Clinical Investigation·Hua Zhang, A S Verkman
Jul 13, 2013·Inflammopharmacology·E Mendez-Enriquez, E A García-Zepeda
Aug 13, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Samira SaadounMarios C Papadopoulos
Jun 21, 2015·Neurology·Dean M WingerchukUNKNOWN International Panel for NMO Diagnosis
May 13, 2017·Frontiers in Immunology·Nicola L DinyDaniela Čiháková

❮ Previous
Next ❯

Citations

May 3, 2020·Expert Review of Neurotherapeutics·Maria A RoccaMassimo Filippi
May 31, 2019·Neurological Research·Efthimios DardiotisGeorgios M Hadjigeorgiou
May 1, 2021·Multiple Sclerosis and Related Disorders·Li DuLinlin Yin
Jun 24, 2021·Seizure : the Journal of the British Epilepsy Association·Luca BartoliniSteven Jacobson

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Software Mentioned

SPSS

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.